Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed study information regarding a Phase I/II trial for Head and Neck Squamous Cell Carcinoma, while adding new collaborators and a revision number.SummaryDifference35%
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.6%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has updated its date references, removing older dates and adding new ones for March 2025.SummaryDifference0.3%
- Check56 days agoChange DetectedThe webpage has updated its date references, removing several past dates from late 2024 and adding new dates in early 2025.SummaryDifference1%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.